Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)

v3.19.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
6 Months Ended
Feb. 28, 2019
Feb. 28, 2018
Cash flows used in operating activities    
Net loss for the period $ (1,854,502) $ (1,957,091)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock based compensation 64,044 122,562
Depreciation and amortization 11,689 837
Inventory write-off (Note 7) 8,984
Shares issued for services 131,000 183,426
Warrants issued for services 717,880
Unrealized loss on marketable securities 9,521
Change in working capital:    
Accounts and other receivables (9,604) (142,992)
Inventory (20,785) (4,336)
Prepaid expenses 44,629 (27,156)
Accounts payable and accrued liabilities 458,673 30,873
Due to related parties (2,234) (37,096)
Unearned revenue (17,083)
Net cash used in operating activities (1,167,569) (1,121,192)
Cash flows used in investing activities    
Investment in Poviva (70,000)
Investment from Altria (Note 3) 1,000,000
Patent (55,743) (32,042)
Property & Equipment (441,150)
Net cash used in investing activities (503,107) (102,042)
Cash flows from financing activities    
Proceeds from issuance of equity 2,030,489 1,007,591
Net cash from financing activities 2,030,489 1,007,591
Increase (decrease) in cash 1,366,027 (215,643)
Cash, beginning of period 1,727,184 2,533,337
Cash, end of period 3,093,211 2,317,694
Supplemental information of cash flows:    
Common shares issued to settle accounts payable 12,000
Income tax paid in cash 13,869
Reclassification of NCI to additional paid in capital on acquisition 238,476
Subscription funds payable $ 31,500